Literature DB >> 2845954

Fatty acids stimulate phosphatidylcholine synthesis and CTP:choline-phosphate cytidylyltransferase in type II pneumocytes isolated from adult rat lung.

R Burkhardt1, P Von Wichert, J J Batenburg, L M Van Golde.   

Abstract

The regulation by cyclic AMP and fatty acids of phosphatidylcholine (PC) synthesis in rat alveolar type II cells was studied. In contrast with results with hepatocytes, cyclic AMP and its potent chlorophenylthio analogue had no inhibitory effect on [Me-14C]choline incorporation into PC in pulse-chase studies with alveolar type II cells. The inclusion of the fatty acids palmitate, oleate or linoleate in the chase incubation medium stimulated the incorporation of [Me-14C]choline into PC by type II cells. The effect of palmitate, which was more pronounced than that of the other fatty acids, appeared to be concentration-dependent. Increased [Me-14C]choline incorporation into PC was paralleled by an accelerated disappearance of the radiolabel from choline phosphate, which is consistent with an activation of CTP:choline-phosphate cytidylyltransferase. This enzyme is considered to be rate-limiting in the synthesis of PC de novo by type II cells. As fatty acids are also substrate for PC synthesis, their effect could also be due to compensation for a fatty acid deficiency. To test this possibility, fatty acid synthesis in the type II cells was stimulated by addition of lactate. Even then, an additional stimulation of PC synthesis by palmitate was observed, which supports the regulatory influence of exogenous fatty acids. Incubation of type II cells in the presence of 0.2 mM-palmitate resulted in a 45% increase in the membrane-bound CTP:choline-phosphate cytidylyltransferase activity, whereas the soluble activity remained unchanged. Choline kinase activity in the soluble fraction increased by 48%. However, the increase in choline kinase is unlikely to be responsible for the increased metabolic flux through the choline phosphate pathway, because there is a relatively large pool of choline phosphate in type II cells. Therefore it is suggested that the microsomal CTP:choline-phosphate cytidylyltransferase is the form of this enzyme which is active in surfactant PC synthesis, and possibly has a regulatory role in this pathway.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845954      PMCID: PMC1135105          DOI: 10.1042/bj2540495

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  The purification and characterization of CTP:phosphorylcholine cytidylyltransferase from rat liver.

Authors:  P A Weinhold; M E Rounsifer; D A Feldman
Journal:  J Biol Chem       Date:  1986-04-15       Impact factor: 5.157

2.  Metabolic fate of fatty acids in type II cells isolated from adult rat lung.

Authors:  I G Stantcheva; M Post; J J Batenburg; L M Van Golde
Journal:  Lung       Date:  1982       Impact factor: 2.584

3.  The stimulation and binding of CTP: phosphorylcholine cytidylyltransferase by phosphatidylcholine-oleic acid vesicles.

Authors:  D A Feldman; M E Rounsifer; P A Weinhold
Journal:  Biochim Biophys Acta       Date:  1985-03-06

4.  Analysis of the effects of fatty acids and related compounds on the synthesis of phosphatidylcholine in lymphocytes.

Authors:  D S Whitlon; K E Anderson; G C Mueller
Journal:  Biochim Biophys Acta       Date:  1985-07-09

5.  Inhibition of foetal pulmonary choline-phosphate cytidylyltransferase under conditions favouring protein phosphorylation.

Authors:  K Radika; F Possmayer
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

6.  Regulation of CTP: phosphocholine cytidylyltransferase activity in type II pneumonocytes.

Authors:  M Tesan; M M Anceschi; J E Bleasdale
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

7.  Effects of fatty acids on phosphatidylcholine biosynthesis in isolated hamster heart.

Authors:  T Mock; T L Slater; G Arthur; A C Chan; P C Choy
Journal:  Biochem Cell Biol       Date:  1986-05       Impact factor: 3.626

8.  An improved method for isolating type II cells in high yield and purity.

Authors:  L G Dobbs; R Gonzalez; M C Williams
Journal:  Am Rev Respir Dis       Date:  1986-07

9.  Stimulation of phosphatidylcholine synthesis by fatty acids in fetal rabbit type II pneumocytes.

Authors:  E E Aeberhard; C T Barrett; S A Kaplan; M L Scott
Journal:  Biochim Biophys Acta       Date:  1986-01-03

10.  Role of fatty acid structure in the reversible activation of phosphatidylcholine synthesis in lymphocytes.

Authors:  K E Anderson; D S Whitlon; G C Mueller
Journal:  Biochim Biophys Acta       Date:  1985-07-09
View more
  6 in total

1.  The effects of dietary fish oil on alveolar type II cell fatty acids and lung surfactant phospholipids.

Authors:  R C Baybutt; J E Smith; Y Y Yeh
Journal:  Lipids       Date:  1993-03       Impact factor: 1.880

2.  Androgen regulation of lung lipids in the male rat.

Authors:  M S Ojeda; N Gomez; M S Giménez
Journal:  Lipids       Date:  1997-01       Impact factor: 1.880

3.  Stimulation of phosphatidylcholine biosynthesis in mouse MLE-12 type-II cells by conditioned medium from cortisol-treated rat fetal lung fibroblasts.

Authors:  J I MacDonald; F Possmayer
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

4.  Effects of antiulcer drugs on phosphatidylcholine synthesis in isolated guinea pig gastric glands.

Authors:  H Nishisaki; C Sakamoto; Y Konda; O Nakano; T Matozaki; M Nagao; K Matsuda; K Wada; M Kasuga
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

5.  Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo.

Authors:  T E Bapiro; K K Frese; A Courtin; J L Bramhall; B Madhu; N Cook; A Neesse; J R Griffiths; D A Tuveson; D I Jodrell; F M Richards
Journal:  Br J Cancer       Date:  2014-05-29       Impact factor: 7.640

Review 6.  Picornavirus inhibitors.

Authors:  L Carrasco
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.